Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Genetic Profile and Microsatellite Instability in a Case of Secondary Esophageal Squamous Cell Carcinoma 12 Years After Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia

Akiyama, Masaharu MD, PhD*; Yamaoka, Masayoshi MD*; Ohyama, Wataru MD*; Yokoi, Kentaro MD, PhD*; Ashizuka, Shuichi MD, PhD; Aizawa, Daisuke MD, PhD; Ikegami, Masahiro MD, PhD; Suzuki, Hideaki MD, PhD§; Ozaki, Koji BSc; Ida, Hiroyuki MD, PhD*; Yuza, Yuki MD, PhD*

Journal of Pediatric Hematology/Oncology: November 28, 2018 - Volume Publish Ahead of Print - Issue - p
doi: 10.1097/MPH.0000000000001355
Clinical and Laboratory Observations: PDF Only
Buy
SDC
PAP

We report on a 16-year-old Japanese boy in whom an esophageal squamous cell carcinoma (ESCC) developed 12 years after allogeneic hematopoietic stem cell transplantation was performed for aplastic anemia. A high frequency of microsatellite instability was detected in samples of ESCC. Moreover, the detection of pathogenic variants, including single nucleotide substitution of TP53 (c.346C>T) and BRCA2 (c.6952C>T) and splicing of KDM6A (c.1194+2T>G), suggest that the development of ESCC in the patient was triggered by impairment of checkpoint and repair for DNA damage and epigenetic modification through accumulation of gene mutations induced by chronic graft-versus-host disease and prolonged administration of tacrolimus.

Departments of *Pediatrics

Pediatric Surgery

Pathology

§Anatomy

Division of Molecular Genetics, Research Center for Medical Science, Core Research Facilities for Basic Science, The Jikei University School of Medicine, Tokyo, Japan

The study was supported by The Jikei University Research Fund (to M.A.).

The authors declare no conflict of interest.

Reprints: Masaharu Akiyama, MD, PhD, Department of Pediatrics, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan (e-mail: makiyama@jikei.ac.jp).

Received August 13, 2018

Accepted October 14, 2018

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.